Jci_page_head_homepage_01 Jci_page_head_homepage_02
Peggy C.R. Godschalk, Astrid P. Heikema, Michel Gilbert, Tomoko Komagamine, C. Wim Ang, Jobine Glerum, Denis Brochu, Jianjun Li, Nobuhiro Yuki, Bart C. Jacobs, Alex van Belkum, Hubert P. Endtz
Published in Volume 114, Issue 11
J Clin Invest. 2004; 114(11):1659–1665 doi:10.1172/JCI15707
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 4

SDS-PAGE analysis of LOS from GB11 WT and mutants. The genome strain NCTC 11168 was included as a control. Lane 1, WT GB11; lane 2, GB11 cst-II mutant; lane 3, GB11 orf10/orf11 mutant; lane 4, GB11 orf11 mutant; lane 5, NCTC 11168. (A) Silver staining of the LOS revealed faster-migrating LOS cores for the GB11 cst-II and orf10/orf11 mutants compared with the WT, indicating that these mutants have a truncated LOS. The orf11 mutant LOS showed migration patterns identical to those of WT LOS. (B) A Western blot incubated with GB11 patient serum showed a reduced reactivity for the cst-II and orf10/orf11 mutants but unchanged reactivity for the orf11 mutant when compared with the WTs. (C) For the cst-II and orf10/orf11 mutants, the reactivity with cholera toxin, a ligand for GM1-oligosaccharide structures, was almost completely lost. Reactivity with the orf11 mutant remained unchanged.